Clover Health Investments Down Nearly 21%, on Pace for Largest Percent Decrease Since June 2021 -- Data Talk

Dow Jones11-06

Clover Health Investments Corp. Class A ( CLOV ) is currently at $2.78, down $0.74 or 20.88%

 

--Would be lowest close since Oct. 17, 2025, when it closed at $2.71

--On pace for largest percent decrease since June 9, 2021, when it fell 23.61%

--Currently down two consecutive days; down 24.32% over this period

--Worst two day stretch since the two days ending June 10, 2021, when it fell 35.26%

--Down 11.59% year-to-date; on pace for worst year since 2022, when it fell 75.01%

--Down 87.43% from its all-time closing high of $22.15 on June 8, 2021

--Down 35.98% from 52 weeks ago (Nov. 6, 2024), when it closed at $4.35

--Down 42.22% from its 52-week closing high of $4.82 on Jan. 24, 2025

--Up 27.75% from its 52-week closing low of $2.18 on Aug. 8, 2025

--Traded as low as $2.59; lowest intraday level since Oct. 14, 2025, when it hit $2.55

--Down 26.42% at today's intraday low; largest intraday percent decrease since Nov. 7, 2023, when it fell as much as 27.34%

 

All data as of 11:27:30 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 05, 2025 11:32 ET (16:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment